Biological implications of oxidation and unidirectional chiral inversion of D-amino acids

Current Drug Metabolism

Volumn 13, Issue 3, 2012, Pages 321-331

  Wang, Yong Xiang ^a   Gong, Nian ^a   Xin, Yan Fei ^b   Hao, Bin ^a   Zhou, Xiang Jun ^a   Pang, Catherine C Y ^c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

D amino acid; D amino acid oxidase (DAAO); Kidney; N G nitro D arginine (D NNA); Transaminase; Unidirectional chiral inversion

Indexed keywords

2 OXOACID; AMINOTRANSFERASE; AMMONIA; DEXTRO AMINO ACID OXIDASE; DOPA; HYDROGEN PEROXIDE; LEUCINE; METHIONINE; N(G) NITRO DEXTRO ARGININE METHYL ESTER; PHENYLALANINE; SERINE;

AMINO ACID METABOLISM; ARTICLE; CHIRAL CHROMATOGRAPHY; CHIRALITY; DEAMINATION; ENANTIOMER; ENZYME ACTIVITY; HUMAN; NEPHROTOXICITY; NONHUMAN; PARKINSON DISEASE;

AMINO ACIDS; ANIMALS; BRAIN; D-AMINO-ACID OXIDASE; HUMANS; KIDNEY; OXIDATION-REDUCTION; STEREOISOMERISM;

EID: 84857489057     PISSN: 13892002     EISSN: 18755453     Source Type: Journal    
DOI: 10.2174/138920012799320392     Document Type: Article

References (70)

1. Pilone, M. S. D-Amino acid oxidase: new findings. Cell Mol. Life Sci., 2000, 57 12, 1732-1747.
2. Pollegioni, L.; Piubelli, L.; Sacchi, S.; Pilone, M. S.; Molla, G. Physiological functions of D-amino acid oxidases: from yeast to humans. Cell Mol. Life Sci., 2007, 64(11), 1373-1394.
3. Dunlop, D. S.; Neidle, A.; McHale, D.; Dunlop, D. M.; Lajtha, A. The presence of free D-aspartic acid in rodents and man. Biochem. Biophys. Res. Commun., 1986, 141(1), 27-32.
4. Hashimoto, A.; Nishikawa, T.; Hayashi, T.; Fujii, N.; Harada, K.; Oka, T.; Takahashi, K. The presence of free D-serine in rat brain. FEBS Lett., 1992, 296 1, 33-36.
5. Hashimoto, A.; Kumashiro, S.; Nishikawa, T.; Oka, T.; Takahashi, K.; Mito, T.; Takashima, S.; Doi, N.; Mizutani, Y.; Yamazaki, T.; et al. Embryonic development and postnatal changes in free Daspartate and D-serine in the human prefrontal cortex. J. Neurochem., 1993, 61 1, 348-351.
6. Morikawa, A.; Hamase, K.; Inoue, T.; Konno, R.; Niwa, A.; Zaitsu, K. Determination of free D-aspartic acid, D-serine and D-alanine in the brain of mutant mice lacking D-amino acid oxidase activity. J. Chromatogr. B. Biomed. Sci. Appl., 2001, 757 1, 119-125.
7. Hamase, K.; Homma, H.; Takigawa, Y.; Fukushima, T.; Santa, T.; Imai, K. Regional distribution and postnatal changes of D-amino acids in rat brain. Biochim. Biophys. Acta, 1997, 1334(2-3), 214-222.
8. Hamase, K.; Inoue, T.; Morikawa, A.; Konno, R.; Zaitsu, K. Determination of free D-proline and D-leucine in the brains of mutant mice lacking D-amino acid oxidase activity. Anal. Biochem., 2001, 298 2, 253-258.
9. Friedman, M. Chemistry, nutrition, and microbiology of D-amino acids. J. Agric. Food Chem., 1999, 47 9, 3457-3479.
10. Williams, M. Commentary: Genome-based CNS drug discovery: D-Amino acid oxidase (DAAO) as a novel target for antipsychotic medications: Progress and challenges. Biochem. Pharmacol., 2009, 78 11, 1360-1365.
11. Xin, Y. F.; Zhou, X. J.; Cheng, X.; Wang, Y. X. Renal D-amino acid oxidase mediates chiral inversion of N (G)-nitro-D-arginine. J. Pharmacol. Exp. Ther., 2005, 312(3), 1090-1096.
12. Xin, Y. F.; Li, X.; Hao, B.; Gong, N.; Sun, W. Q.; Konno, R.; Wang, Y. X. Indispensable but insufficient role of renal D-amino acid oxidase in chiral inversion of NG-nitro-D-arginine. Chem. Biodivers., 2010, 7 6, 1413-1423.
13. Nishimura, K.; Ito, J.; Yoshimura, T.; Esaki, N.; Soda, K. A simple method for determination of stereospecificity of aminotransferases for C-4' hydrogen transfer of the coenzyme. Bioorg. Med. Chem., 1994, 2(7), 605-607.
14. Cooper, A. J. The role of glutamine transaminase K (GTK) in sulfur and alpha-keto acid metabolism in the brain, and in the possible bioactivation of neurotoxicants. Neurochem. Int., 2004, 44(8), 557-577.
15. Lu, J. M.; Gong, N.; Wang, Y. C.; Wang, Y. X. DAAO-mediated spinal hydrogen peroxide is specifically and largely responsible for formalin-induced central sensitization-involved pain. Br. J. Pharmacol., 2011, doi: 10.1111/j.1476-5381.2011.01680.x.
16. Davankov, V. A. Enantioselective ligand exchange in modern separation techniques. J. Chromatogr. A., 2003, 1000(1-2), 891-915.
17. Ilisz, I.; Berkecz, R.; Peter, A. Application of chiral derivatizing agents in the high-performance liquid chromatographic separation of amino acid enantiomers: a review. J. Pharm. Biomed. Anal., 2008, 47(1), 1-15.
18. Moncada, S.; Palmer, R. M.; Higgs, E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 1991, 43 2, 109-142.
19. Wang, Y. X.; Poon, C. I.; Pang, C. C. Vascular pharmacodynamics of NG-nitro-L-arginine methyl ester in vitro and in vivo. J. Pharmacol. Exp. Ther., 1993, 267 3, 1091-1099.
20. Wang, Y. X.; Zhou, T.; Pang, C. C. Pressor effects of L and D enantiomers of NG-nitro-arginine in conscious rats are antagonized by L-but not D-arginine. Eur. J. Pharmacol., 1991, 200 1, 77-81.
21. Wang, Y. X.; Pang, C. C. Pressor effect of NG-nitro-L-arginine in pentobarbital-anesthetized rats. Life Sci., 1990, 47 24, 2217-2224.
22. Wang, Q.; Cwik, M.; Wright, C. J.; Cunningham, F.; Pelligrino, D. A. The in vivo unidirectional conversion of nitro-D-arginine to nitro-L-arginine. J. Pharmacol. Exp. Ther., 1999, 288 1, 270-273.
23. Wang, Y. X.; Poon, C. I.; Pang, C. C. In vitro and ex vivo inhibitory effects of L-and D-enantiomers of NG-nitro-arginine on endothelium-dependent relaxation of rat aorta. J. Pharmacol. Exp. Ther., 1993, 265 1, 112-119.
24. Wang, Y. X.; Poon, C. I.; Yau, L. C. Y.; Pang, C. C. Y. The in vitro and in vivo vasoconstrictor effects of L and D enantiomers of NGnitroarginine methyl ester. Can Fed. Biol. Soc., 1992, 35, 80.
25. Wang, Y. X.; Pang, C. C. Y. Effects of L and D enantiomers of NGnitroarginine on blood pressure in pentobarbital-anesthetized rats. Pharmacology (Life Sci. Adv.), 1990, 9, 723-728.
26. Cheng, X.; Wang, Y. X.; Pang, C. C. Reversal by L-and Denantiomers of NG-nitro-arginine of endotoxin-induced hypotension and vascular hyporesponsiveness. J. Cardiovasc. Pharmacol., 1996, 28(1), 75-81.
27. Abdelrahman, A.; Wang, Y. X.; Chang, S. D.; Pang, C. C. Mechanism of the vasodilator action of calcitonin gene-related peptide in conscious rats. Br. J. Pharmacol., 1992, 106 1, 45-48.
28. Cheng, X.; Wang, Y. X.; Pang, C. C. Y. Biological activation of NGnitro-D-arginine by kidney homogenate. Naunyn-Schmiedeberg's archives of pharmacology, 1997, 356(4), 495-499.
29. Xin, Y. F.; Zhou, X. J.; Lu, J.; Wang, Y. X. Inhibitory effects of benzoate on chiral inversion and clearance of N-G-nitro-arginine in conscious rats. Drug Metab. Dispos., 2007, 35(3), 331-334.
30. Xin, Y. F.; Tong, R.; Fang, Y.; Zhou, X. J.; Wang, Y. X. Chiral pharmacokinetics and inversion of NG-nitro-arginine in rats. Chin. Pharmacol. Bull., 2005, 21(1), 38-41.
31. Xin, Y. F.; Cheng, X.; Wang, G. J.; Zhou, X. J.; Wang, Y. X. Kidney is the main organ on NG-nitro-D-arginine chiral inversion in rats. Chin. Pharmacol. Bull., 2004, 20(9), 989-993.
32. Xin, Y. F.; Gu, L. Q.; Zhang, S.; Bai, Y. S.; Zhou, G. L.; You, Z. Q.; Xuan, Y. X. Stereospecific pharmacodynamics and chiral inversion of NG-nitro-arginine in the beagle dogs. Chirality, 2010, 22 10, 896-900.
33. Hasegawa, H.; Matsukawa, T.; Shinohara, Y.; Hashimoto, T. Assessment of the metabolic chiral inversion of D-leucine in rat by gas chromatography-mass spectrometry combined with a stable isotope dilution analysis. Drug Metab. Dispos., 2000, 28 8, 920-924.
34. Hasegawa, H.; Matsukawa, T.; Shinohara, Y.; Hashimoto, T. Kinetics of sequential metabolism from D-leucine to L-leucine via alpha-ketoisocaproic acid in rat. Drug Metab. Dispos., 2002, 30 12, 1436-1440.
35. Hasegawa, H.; Matsukawa, T.; Shinohara, Y.; Konno, R.; Hashimoto, T. Role of renal D-amino-acid oxidase in pharmacokinetics of D-leucine. Am. J. Physiol. Endocrinol. Metab., 2004, 287(1), E160-165.
36. Hasegawa, H.; Shinohara, Y.; Akahane, K.; Hashimoto, T. Determination of D-and L-enantiomers of methionine and [2H3]methionine in plasma by gas chromatography-mass spectrometry. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci., 2005, 823(2), 203-208.
37. Hasegawa, H.; Shinohara, Y.; Akahane, K.; Hashimoto, T. Direct detection and evaluation of conversion of D-methionine into Lmethionine in rats by stable isotope methodology. J. Nutr., 2005, 135(8), 2001-2005.
38. Hasegawa, H.; Shinohara, Y.; Akahane, K.; Hashimoto, T.; Ichida, K. Altered d-methionine kinetics in rats with renal impairment. Amino Acids, 2011, 40 4, 1205-1211.
39. Lehmann, W. D.; Theobald, N.; Fischer, R.; Heinrich, H. C. Stereospecificity of phenylalanine plasma kinetics and hydroxylation in man following oral application of a stable isotopelabelled pseudo-racemic mixture of L-and D-phenylalanine. Clin. Chim. Acta, 1983, 128(2-3), 181-198.
40. Brannan, T.; Prikhojan, A.; Yahr, M. D. Elevated striatal dopamine levels following administration of D-DOPA and its alpha-keto acid metabolite DHPPA: behavioral and physiological studies in vivo in the rat. Brain Res., 1996, 718(1-2), 165-168.
41. Wu, M.; Zhou, X. J.; Konno, R.; Wang, Y. X. D-dopa is unidirectionally converted to L-dopa by D-amino-acid oxidase followed by dopa transaminase. Clin. Exp. Pharmacol. P., 2006, 33 11, 1042-1046.
42. Vanoni, M. A.; Cosma, A.; Mazzeo, D.; Mattevi, A.; Todone, F.; Curti, B. Limited proteolysis and X-ray crystallography reveal the origin of substrate specificity and of the rate-limiting product release during oxidation of D-amino acids catalyzed by mammalian D-amino acid oxidase. Biochemistry, 1997, 36 19, 5624-5632.
43. Gong, N.; Gao, Z. Y.; Wang, Y. C.; Li, X. Y.; Huang, J. L.; Hashimoto, K.; Wang, Y. X. A series of D-amino acid oxidase inhibitors specifically prevents and reverses formalin-induced tonic pain in rats. J. Pharmacol. Exp. Ther., 2011, 336 1, 282-293.
44. Konno, R.; Yasumura, Y. Mouse mutant deficient in D-amino acid oxidase activity. Genetics, 1983, 103 2, 277-285.
45. Sasaki, M.; Konno, R.; Nishio, M.; Niwa, A.; Yasumura, Y.; Enami, J. A single-base-pair substitution abolishes D-amino-acid oxidase activity in the mouse. Biochim. Biophys. Acta, 1992, 1139 4, 315-318.
46. Zhao, W.; Konno, R.; Zhou, X. J.; Yin, M.; Wang, Y. X. Inhibition of D-amino-Acid oxidase activity induces pain relief in mice. Cell. Mol. Neurobiol., 2008, 28 4, 581-591.
47. Zhao, W. J.; Gao, Z. Y.; Wei, H.; Nie, H. Z.; Zhao, Q.; Zhou, X. J.; Wang, Y. X. Spinal D-amino acid oxidase contributes to neuropathic pain in rats. J. Pharmacol. Exp. Ther., 2010, 332 1, 248-254.
48. Konno, R.; Yasumura, Y. Involvement of D-amino-acid oxidase in D-amino acid utilization in the mouse. J. Nutr., 1984, 114 9, 1617-1621.
49. D'Aniello, A.; D'Onofrio, G.; Pischetola, M.; D'Aniello, G.; Vetere, A.; Petrucelli, L.; Fisher, G. H. Biological role of D-amino acid oxidase and D-aspartate oxidase. Effects of D-amino acids. J. Biol. Chem., 1993, 268 36, 26941-26949.
50. Moses, J.; Siddiqui, A.; Silverman, P. B. Sodium benzoate differentially blocks circling induced by D-and L-dopa in the hemiparkinsonian rat. Neurosci. Lett., 1996, 218 3, 145-148.
51. Kawazoe, T.; Park, H. K.; Iwana, S.; Tsuge, H.; Fukui, K. Human D-amino acid oxidase: an update and review. Chem. Rec., 2007, 7 5, 305-315.
52. Maekawa, M.; Okamura, T.; Kasai, N.; Hori, Y.; Summer, K. H.; Konno, R. D-Amino-acid oxidase is involved in D-serine-induced nephrotoxicity. Chem. Res. Toxicol., 2005, 18 11, 1678-1682.
53. Williams, R. E.; Lock, E. A. Sodium benzoate attenuates D-serine induced nephrotoxicity in the rat. Toxicology, 2005, 207 1, 35-48.
54. Krug, A. W.; Volker, K.; Dantzler, W. H.; Silbernagl, S. Why is Dserine nephrotoxic and alpha-aminoisobutyric acid protective? Am. J. Physiol. Renal Physiol., 2007, 293 1, F382-390.
55. Momoi, K.; Fukui, K.; Watanabe, F.; Miyake, Y. Molecular cloning and sequence analysis of cDNA encoding human kidney D-amino acid oxidase. FEBS Lett., 1988, 238 1, 180-184.
56. Konno, R.; Sasaki, M.; Asakura, S.; Fukui, K.; Enami, J.; Niwa, A. D-amino-acid oxidase is not present in the mouse liver. Biochim. Biophys. Acta, 1997, 1335(1-2), 173-181.
57. Wang, Y. X.; Cheng, X.; Pang, C. C. Bilateral kidney ligation abolishes pressor response to N (G)-nitro-D-arginine. Eur. J. Pharmacol., 1999, 366(2-3), 175-179.
58. Nagata, Y.; Akino, T.; Ohno, K.; Kataoka, Y.; Ueda, T.; Sakurai, T.; Shiroshita, K.; Yasuda, T. Free D-amino acids in human plasma in relation to senescence and renal diseases. Clin. Sci. (Lond)., 1987, 73 1, 105-108.
59. Young, G. A.; Kendall, S.; Brownjohn, A. M. D-Amino acids in chronic renal failure and the effects of dialysis and urinary losses Amino Acids, 1994, 6, 283-293.
60. Konno, R.; Isobe, K.; Niwa, A.; Yasumura, Y. Lack of D-aminoacid oxidase activity causes a specific renal aminoaciduria in the mouse. Biochim. Biophys. Acta, 1988, 967 3, 382-390.
61. Xin, Y. F.; Zhou, X. J.; Wang, Y. X. Effects of D-amino acid oxidase on chiral inversion of NG-nitro-D-arginine. Prog. Biochem. Biophys., 2006, 33, 135-139.
62. D'Aniello, A.; Vetere, A.; Petrucelli, L. Further study on the specificity of D-amino acid oxidase and D-aspartate oxidase and time course for complete oxidation of D-amino acids. Comp. Biochem. Physiol., 1993, 105(3-4), 731-734.
63. Dolle, A. Metabolism of D-and L-[(13) C]alanine in rat liver detected by (1) H and (13) C NMR spectroscopy in vivo and in vitro. NMR Biomed., 2000, 13 2, 72-81.
64. Zhang, H.; Qi, L.; Lin, Y.; Mao, L.; Chen, Y. Study on the decrease of renal D-amino acid oxidase activity in the rat after renal ischemia by chiral ligand exchange capillary electrophoresis. Amino Acids, 2010, DOI: 10.1007/s00726-00010-00811-00720.
65. Horio, M.; Fujita, Y.; Ishima, T.; Iyo, M.; Ferraris, D.; Tsukamoto, T.; Hashimoto, K. Effects of D-Amino Acid Oxidase Inhibitor on the Extracellular D-Alanine Levels and the Efficacy of D-Alanine on Dizocilpine-Induced Prepulse Inhibition Deficits in Mice. Open Clinic. Chem. J., 2009, 2, 16-21.
66. Smith, S. M.; Uslaner, J. M.; Yao, L.; Mullins, C. M.; Surles, N. O.; Huszar, S. L.; McNaughton, C. H.; Pascarella, D. M.; Kandebo, M.; Hinchliffe, R. M.; Sparey, T.; Brandon, N. J.; Jones, B.; Venkatraman, S.; Young, M. B.; Sachs, N.; Jacobson, M. A.; Hutson, P. H. The behavioral and neurochemical effects of a novel D-amino acid oxidase inhibitor compound 8 [4H-thieno [3, 2-b]pyrrole-5-carboxylic acid] and D-serine. J. Pharmacol. Exp. Ther., 2009, 328 3, 921-930.
67. Adage, T.; Trillat, A. C.; Quattropani, A.; Perrin, D.; Cavarec, L.; Shaw, J.; Guerassimenko, O.; Giachetti, C.; Greco, B.; Chumakov, I.; Halazy, S.; Roach, A.; Zaratin, P. In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties. Eur. Neuropsychopharmacol., 2008, 18 3, 200-214.
68. Smith, S. M.; Uslaner, J. M.; Hutson, P. H. The Therapeutic Potential of D-Amino Acid Oxidase (DAAO) Inhibitors. Open Med. Chem. J., 2010, 4, 3-9.
69. Prabakaran, S.; Swatton, J. E.; Ryan, M. M.; Huffaker, S. J.; Huang, J. T.; Griffin, J. L.; Wayland, M.; Freeman, T.; Dudbridge, F.; Lilley, K. S.; Karp, N. A.; Hester, S.; Tkachev, D.; Mimmack, M. L.; Yolken, R. H.; Webster, M. J.; Torrey, E. F.; Bahn, S. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol. Psychiatry, 2004, 97, 684-697, 643.
70. Khoronenkova, S. V.; Tishkov, V. I. D-amino acid oxidase: physiological role and applications. Biochemistry (Mosc)., 2008, 73 13, 1511-1518.